Skip to main content

Table 1 Primer Sequences and Reaction Properties

From: Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis

Target

 

Sequence

Product Size (bp)

Annealing temp. (°C)

Human

    

PKCζ

forward

CTGAGGAGCACGCCAGGTT

625

58.1

reverse

ACGGGCTCGCTGGTGAACT

COX-2

forward

TCTGCAGAGTTGGAAGCA-CTCTA

216

58.4

reverse

GCCGAGGCTTTTCTACCAGAA

β-actin

forward

CTGGCACCCAGCACAATG

458

54.1

reverse

GCCGATCCACACGGAGTACT

Mouse

    

PKCζ

forward

ACGGACAACCCTGACATGAAC

361

57.1

reverse

ATTCGGACTGGTCGATCCTCT

COX-2

forward

TCAGGTCATTGGTGGAGAGG

96

54

reverse

GCAAACTGCAGGTTCTCAGG

β-actin

forward

ATGGAGCCACCGATCCACA

426

56.2

reverse

CATCCGTAAAGACCTCTATGCCAAC